Old API Wind-down Ltd - Ordinary Shares ARLZQ

"Old API Wind-down Ltd, formerly Aralez Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the acquisition, development, and commercialization of products primarily in cardiovascular, pain management and other specialty areas. Its key products include Fiorinal, Proferrin, Fibricor, Uracyst and Neovisc, Cambia and other marketed products. The company currently operates in two geographical markets, the United States and Canada. The firm generates most of its reven

OTCPK:ARLZQ - Post by User

Old API Wind-down Ltd - Ordinary Shares

<< Previous

Bullboard Posts

Next >>

Post by allison5120on Nov 14, 2016 10:08pm

156 Views

Post# 25460455

"Pleasant Surprises Ahead for Aralez Pharma Shareholders"

Seeking Alpha article explains why ARLZ is grossly undervalued at $5.00. Analysis of underappreciated value of Yosprala, Zontivity and Toprol-XL. Even Toprol-XL sales are on target to hit over $105 million in 2016. AstraZeneca just reports Toprol sales Jan 1 to Sept 30, 2016 of $81 million!! Zontivity is a hidden gem that analysts are giving little value to. Aralez likely a multi-bagger in the next 12 to 18 months. See https://seekingalpha.com/article/4023305-pleasant-surprises-ahead-aralez-pharmaceuticals-shareholders?v=1479166207&commenter=1&comments=show

<< Previous

Bullboard Posts

Next >>

How a junior advances one of the largest undeveloped diamond projects